The report, titled “A Painful Pill to Swallow: U.S. vs. International Prescription Drug Prices,” compared drug prices in the U.S. to drug prices in the United Kingdom, Japan, Ontario, Australia, Portugal, France, the Netherlands, Germany, Denmark, Sweden and Switzerland.
It concluded that Americans pay significantly more than the other countries even when accounting for rebates, and that the U.S. could save $49 billion annually on Medicare Part D alone by pricing drugs similarly to the other countries studied. Most countries had average prices around 24 to 30 percent lower than those in the U.S.
The report illustrates why drugmakers are opposed to House Speaker Nancy Pelosi’s plan, which would allow the U.S. to negotiate drug prices by comparing them to other countries’ prices.
Read the full report here.
More articles on pharmacy:
Carcinogen concerns prompt Sandoz to halt global distribution of heartburn drug
DEA raids some West Coast Kaiser Permanente pharmacies
California biotech files for bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
